ASCO: Non-Small Cell Lung Cancer
<ѻýҕl class="page-description">American Society of Clinical Oncologyѻýҕl>More in ASCO: Non-Small Cell Lung Cancer
The immune-related adverse event is rare and manageable, but not necessarily reversible
Jun 25, 2021